ePrints@IIScePrints@IISc Home | About | Browse | Latest Additions | Advanced Search | Contact | Help

Targeted Redesign of Suramin Analogs for Novel Antimicrobial Lead Development

Dey, D and Ramakumar, S and Conn, GL (2021) Targeted Redesign of Suramin Analogs for Novel Antimicrobial Lead Development. In: Journal of Chemical Information and Modeling .

[img] PDF
jcim_jou_che_2021 - Published Version
Restricted to Registered users only

Download (7MB) | Request a copy
Official URL: https://doi.org/10.1021/acs.jcim.1c00578


The emergence of new viral infections and drug-resistant bacteria urgently necessitates expedient therapeutic development. Repurposing and redesign of existing drugs against different targets are one potential way in which to accelerate this process. Suramin was initially developed as a successful antiparasitic drug but has also shown promising antiviral and antibacterial activities. However, due to its high conformational flexibility and negative charge, suramin is considered quite promiscuous toward positively charged sites within nucleic acid binding proteins. Although some suramin analogs have been developed against specific targets, only limited structure-activity relationship studies were performed, and virtual screening has yet to be used to identify more specific inhibitor(s) based on its scaffold. Using available structures, we investigated suramin's target diversity, confirming that suramin preferentially binds to protein pockets that are both positively charged and enriched in aromatic or leucine residues. Further, suramin's high conformational flexibility allows adaptation to structurally diverse binding surfaces. From this platform, we developed a framework for structure- and docking-guided elaboration of suramin analog scaffolds using virtual screening of suramin and heparin analogs against a panel of diverse therapeutically relevant viral and bacterial protein targets. Use of this new framework to design potentially specific suramin analogs is exemplified using the SARS-CoV-2 RNA-dependent RNA polymerase and nucleocapsid protein, identifying leads that might inhibit a wide range of coronaviruses. The approach presented here establishes a computational framework for designing suramin analogs against different bacterial and viral targets and repurposing existing drugs for more specific inhibitory activity. © 2021 American Chemical Society.

Item Type: Journal Article
Publication: Journal of Chemical Information and Modeling
Publisher: American Chemical Society
Additional Information: The copyright for this article belongs to the American Chemical Society
Keywords: Binding sites; Coronavirus; Diseases; Proteins; SARS; Scaffolds (biology), Antiparasitic drugs; Antiviral activities; Conformational flexibility; Drug-resistant bacteria; Positively charged; Repurposing; Suramin; Viral drugs; Viral infections; Virtual Screening, RNA
Department/Centre: Division of Physical & Mathematical Sciences > Physics
Date Deposited: 28 Nov 2021 09:43
Last Modified: 28 Nov 2021 09:43
URI: http://eprints.iisc.ac.in/id/eprint/70357

Actions (login required)

View Item View Item